entertainment -WSS

entertainment

author：Wikipedia 2025-09-28 21:04:36 - browse：7

Amedisys -- Hospital coverage from STAT — Option Care Health is buying Amedisys, creating a national company that specializes in almost all types of home care. Wikimedia Commons

Option Care Health is buying Amedisys in an all-stock merger valued at $3.6 billion, creating a national company that specializes in almost all types of home care that can be provided from cradle to grave.

Health insurance companies, providers, and patients have pushed for more care to be handled at home instead of a hospital or post-acute facility, under the idea that quality home care saves money and is what patients want. Option Care’s deal for Amedisys marks another instance of this push, and comes just a few months after UnitedHealth Group closed on its $5.4 billion acquisition of LHC Group.

But Wall Street was not receptive to the deal, driving down Option Care’s stock by more than 25% on Thursday morning.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： With Wegovy coverage, Medicare patients may face high costs

WSS

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Pregnancy discrimination could be enabled by AI

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Erich Jarvis studies song birds to learn about human stuttering

Testing GLP

Steward Health Care expansion into Malta flopped

leisure time

entertainment

Wikipedia

Medical leaders decry Supreme Court decision on affirmative action

FDA approves world's first CRISPR

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Medicare Advantage insurers pressure Biden for bigger payments

Apple is now the first public company to be valued at $3 trillion

Medical devices makers are asking for forgiveness, not permission

Bright Health sells Medicare Advantage business to Molina

6 surprising facts about sugar

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: Illumina, CRISPR, Regeneron

knowledge

Medicare Advantage insurers pressure Biden for bigger payments

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

AI models in health care face new federal disclosure requirements

Asbestos ban is immediate, but health effects will linger for decades

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

FDA approves world's first CRISPR

entertainment

knowledge

hotspot

hotspot